145 related articles for article (PubMed ID: 15454199)
1. Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer.
Chehal A; Taher A; Khalil M; Shamseddine A
Breast; 2004 Oct; 13(5):421-4. PubMed ID: 15454199
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin and vinorelbine (PVn) for the treatment of advanced breast cancer: 10 years of experience.
Shamseddine A; El-Saghir N; Chehal A; Saliba T; Taher A
J Med Liban; 2004; 52(3):126-30. PubMed ID: 16432968
[TBL] [Abstract][Full Text] [Related]
3. A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer.
Cassier PA; Ray-Coquard I; Sunyach MP; Lancry L; Guastalla JP; Ferlay C; Gomez F; Curé H; Lortholary A; Claude L; Blay JY; Bachelot T
Cancer; 2008 Nov; 113(9):2532-8. PubMed ID: 18780315
[TBL] [Abstract][Full Text] [Related]
4. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Ardavanis A; Mavroudis D; Kalbakis K; Malamos N; Syrigos K; Vamvakas L; Kotsakis A; Kentepozidis N; Kouroussis C; Agelaki S; Georgoulias V;
Cancer Chemother Pharmacol; 2006 Dec; 58(6):742-8. PubMed ID: 16718470
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
6. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
Fanale MA; Uyei AR; Theriault RL; Adam K; Thompson RA
Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
[TBL] [Abstract][Full Text] [Related]
9. Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes.
Toi M; Saeki T; Aogi K; Sano M; Hatake K; Asaga T; Tokuda Y; Mitsuyama S; Kimura M; Kobayashi T; Tamura M; Tabei T; Shin E; Nishimura R; Ohno S; Takashima S
Jpn J Clin Oncol; 2005 Jun; 35(6):310-5. PubMed ID: 15930037
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
Ma CD; Chen CM; Chen XS; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen ZZ; Shen KW
Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC
Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin plus vinorelbine as a salvage regimen in refractory breast cancer.
Günel N; Akçali Z; Yamaç D; Onuk E; Yilmaz E; Bayram O; Tekin E; Coşkun U
Tumori; 2000; 86(4):283-5. PubMed ID: 11016704
[TBL] [Abstract][Full Text] [Related]
13. Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.
Zekri JM; El-Helw LM; Purohit OP; Hatton MQ; Coleman RE
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):513-6. PubMed ID: 18513930
[TBL] [Abstract][Full Text] [Related]
14. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer.
Shamseddine AI; Taher A; Dabaja B; Dandashi A; Salem Z; El Saghir NS
Am J Clin Oncol; 1999 Jun; 22(3):298-302. PubMed ID: 10362341
[TBL] [Abstract][Full Text] [Related]
15. 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.
Barni S; Visini M; Piazza E; Ionta MT; Ardizzoia A; Arnoldi E; Fava S; Pinotti G; Torretta F; Corradini G; Villa S; Nosenzo AM; Massidda B; Cazzaniga ME
Anticancer Res; 2007; 27(4C):3019-24. PubMed ID: 17695490
[TBL] [Abstract][Full Text] [Related]
16. Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.
Abrial C; Van Praagh I; Delva R; Leduc B; Fleury J; Gamelin E; Sillet-Bach I; Penault-Llorca F; Amat S; Chollet P
Oncologist; 2005 Apr; 10(4):242-9. PubMed ID: 15821244
[TBL] [Abstract][Full Text] [Related]
17. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
Delva R; Pienkowski T; Tubiana N; Vanhoefer U; Longerey B; Douville I
Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
[TBL] [Abstract][Full Text] [Related]
18. Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
Saloustros E; Kalbakis K; Vardakis N; Kalykaki A; Milaki G; Rovithi M; Agelaki S; Saridaki Z; Georgoulias V; Mavroudis D
J BUON; 2011; 16(2):215-8. PubMed ID: 21766488
[TBL] [Abstract][Full Text] [Related]
19. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Mlineritsch B; Schabel-Moser R; Andel J; Fridrik M; Moik M; Mayer P; Russ G; Rass C; Greil R;
Onkologie; 2009 Feb; 32(1-2):18-24. PubMed ID: 19209014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
